1. Home
  2. KMDA vs CHCT Comparison

KMDA vs CHCT Comparison

Compare KMDA & CHCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • CHCT
  • Stock Information
  • Founded
  • KMDA 1990
  • CHCT 2014
  • Country
  • KMDA Israel
  • CHCT United States
  • Employees
  • KMDA N/A
  • CHCT N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • CHCT Real Estate Investment Trusts
  • Sector
  • KMDA Health Care
  • CHCT Real Estate
  • Exchange
  • KMDA Nasdaq
  • CHCT Nasdaq
  • Market Cap
  • KMDA 392.2M
  • CHCT 425.5M
  • IPO Year
  • KMDA N/A
  • CHCT 2015
  • Fundamental
  • Price
  • KMDA $6.84
  • CHCT $13.93
  • Analyst Decision
  • KMDA Strong Buy
  • CHCT Buy
  • Analyst Count
  • KMDA 2
  • CHCT 2
  • Target Price
  • KMDA $13.00
  • CHCT $18.00
  • AVG Volume (30 Days)
  • KMDA 56.5K
  • CHCT 204.8K
  • Earning Date
  • KMDA 11-12-2025
  • CHCT 10-28-2025
  • Dividend Yield
  • KMDA 2.92%
  • CHCT 13.61%
  • EPS Growth
  • KMDA 27.97
  • CHCT N/A
  • EPS
  • KMDA 0.32
  • CHCT N/A
  • Revenue
  • KMDA $169,517,000.00
  • CHCT $118,100,000.00
  • Revenue This Year
  • KMDA $14.49
  • CHCT $6.73
  • Revenue Next Year
  • KMDA $10.12
  • CHCT $6.07
  • P/E Ratio
  • KMDA $20.74
  • CHCT N/A
  • Revenue Growth
  • KMDA 9.67
  • CHCT 2.96
  • 52 Week Low
  • KMDA $5.18
  • CHCT $13.89
  • 52 Week High
  • KMDA $9.16
  • CHCT $20.87
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 41.12
  • CHCT 28.15
  • Support Level
  • KMDA $6.50
  • CHCT $14.97
  • Resistance Level
  • KMDA $6.89
  • CHCT $15.48
  • Average True Range (ATR)
  • KMDA 0.13
  • CHCT 0.31
  • MACD
  • KMDA -0.01
  • CHCT -0.12
  • Stochastic Oscillator
  • KMDA 38.50
  • CHCT 3.92

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

Share on Social Networks: